Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Effects of Immunotherapy”

221 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 221 results

Not applicableStudy completedNCT04269629
What this trial is testing

The Effect of Antihypertensive Drugs on Severity of Anaphylaxis and Side-effects During Venom Immunotherapy

Who this might be right for
Hymenoptera Venom AllergyAntihypertensive Treatment
Medical University of Graz 1,425
Not applicableLooking for participantsNCT06727981
What this trial is testing

First-Line and Neoadjuvant Immunotherapy for Gastric Cancer

Who this might be right for
Advanced Gastric CancerLocally Advanced Gastric Carcinoma
Qilu Hospital of Shandong University 500
Testing effectiveness (Phase 2)Study completedNCT03033303
What this trial is testing

The Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 59
Testing effectiveness (Phase 2)Active Not RecruitingNCT04305145
What this trial is testing

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVSkin Cancer Stage III+4 more
Massachusetts General Hospital 42
Not applicableLooking for participantsNCT07354971
What this trial is testing

IMMUNO-FIT Observational Study

Who this might be right for
NeoplasmsImmunotherapyPhysical Fitness+2 more
University Hospital Southampton NHS Foundation Trust 67
Not applicableLooking for participantsNCT05652673
What this trial is testing

Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

Who this might be right for
Melanoma Stage IVMelanoma Stage IIIImmunotherapy+1 more
Erasmus Medical Center 80
Early research (Phase 1)Study completedNCT02164461
What this trial is testing

Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer

Who this might be right for
Effects of ImmunotherapyMetastatic/Recurrent Cervical CancerCervical Adenocarcinoma+6 more
Advaxis, Inc. 12
Post-approval studies (Phase 4)Study completedNCT00691873
What this trial is testing

Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids

Who this might be right for
Asthma
University of Mississippi Medical Center 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07110662
What this trial is testing

New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.

Who this might be right for
Toxic Epidermal NecrolysisImmunotherapyCutaneous Adverse Drug Reactions (CADR)
Hospices Civils de Lyon 9
Testing effectiveness (Phase 2)Study completedNCT00001934
What this trial is testing

Zenapax to Treat Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 22
Not applicableStudy completedNCT04435964
What this trial is testing

Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment

Who this might be right for
MelanomaLung CancerHead and Neck Cancer+2 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 247
Early research (Phase 1)Study completedNCT02659306
What this trial is testing

Metformin Immunotherapy in HIV Infection

Who this might be right for
HIV Infection
McGill University Health Centre/Research Institute of the McGill University Health Centre 22
Early research (Phase 1)Study completedNCT00002268
What this trial is testing

A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Sandoz
Testing effectiveness (Phase 2)WithdrawnNCT01437020
What this trial is testing

SCH708980 With and Without AmBisome for Visceral Leishmaniasis

Who this might be right for
LeishmaniasisEffects of Immunotherapy
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT00418379
What this trial is testing

Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets

Who this might be right for
Allergy
Stallergenes Greer 633
Early research (Phase 1)Study completedNCT05117177
What this trial is testing

New Formulation Study of Inupadenant (EOS100850) in Patients with Cancer

Who this might be right for
Solid Tumor, Adult
iTeos Therapeutics 57
Not applicableEnrolling By InvitationNCT06647836
What this trial is testing

The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous Carcinoma

Who this might be right for
Squamous Cell Lung Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1,000
Large-scale testing (Phase 3)Study completedNCT01731249
What this trial is testing

Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis

Who this might be right for
HypersensitivityAllergic RhinitisAllergic Conjunctivitis+1 more
Stallergenes Greer 574
Early research (Phase 1)Study completedNCT00001647
What this trial is testing

White Blood Cell Infusions to Treat HIV Infection

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)UnknownNCT02305186
What this trial is testing

Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Craig L Slingluff, Jr 68
Load More Results